MSF TB Program for Migrants in Tak. Beginnings: MSF TB Programs in Thailand First MSF TB Program in Thailand started in 1985 in Karen camps (Shoklo,

Slides:



Advertisements
Similar presentations
Implementing a TB-Control Program in Prisons: The Basics Dr. Mayra Arias.
Advertisements

SERVICE DELIVERY AS AN ENTRY POINT TO HEALTH SYSTEM STRENGTHENING A Case Study from Senegal: Improving the Tuberculosis System of Care Dr. Bruno Bouchet,
Planning M&E to Tell Our ACSM Story. Objectives Discuss how ACSM activities can address barriers to help reach national TB control targets. Describe how.
Module 11: Community TB Care Image source: Pierre Virot, World Lung Foundation.
PPM-DOTS in Cambodia Working with Private Pharmacies DOTS Expansion WG Meeting Paris 15 th October 2008 Dr. Mao Tan Eang Director National Center for TB.
Of South Africa DOTS WORKS VWSA WORKPLACE PROGRAM.
Decentralisation as a Strategy to Address Major Challenges of DOTS Services: Experience of Kano State, Nigeria Mahmoud Nasir Mohammed 1, Tijjani Hussaini.
Absorption, Retention and Empowerment
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World TB Day 2011 March 24, 2011 Mavuso Centre Manzini – Kingdom of Swaziland.
Emergency Department Thoracotomy: A Hybrid Simulation With A Clinical Outcome.
Rapporteur: Dr. Massimo Ghidinelli Facilitator: Dr.Elvira Teodora Wi
Accelerating PMDT scale up in Ethiopia
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Rx for Drug-Seeking Patients in the ED The Monterey County Prescribe Safe Initiative 1.
Introduction Thailand one of 22 countries which contain 80% of the estimated tuberculosis (TB) cases in the world. Thailand ranks 17 th among the 22 high-burden.
Rita Ann Classe, RDH, BS HCPI 557: Contemporary Healthcare Issues Texas A&M Health Science Center’s Baylor College of Dentistry.
Dr. Richard B. Munyaneza, MD, Rwanda Ministry of Health.
Standard of Care for MDR-TB
experience from Lesotho
Molecular methods for TB drug resistance testing: what is needed? Experience from Khayelitsha, Cape Town, South Africa Helen Cox, PhD, Burnet Institute.
RNTCP: DOTS Expansion and plans for DOTS-Plus
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Health at Home – The AMPATH Evolution
Multi-drug resistant tuberculosis: Progress and challenges in South Africa Dr S. Moyo HIV/AIDS, Sexually Transmitted Infections and TB research (HAST)Programme.
A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,
TB Care Association1 DOT/ Adherence Cape Town. TB Care Association2 Beautiful City.
Extrapulmonary Site 2 :_____________________ Name (surname, first name) Age (in years) Sex F Alternative address Physical Address (in full) M INTERIM TUBERCULOSIS.
Integrated Health Programs for Women and Children: Lessons from the Field Dr. Ambrose Misore Project Director, APHIA II Western, PATH’s Kenya Country Program.
Integrating Behavioral Health and Medical Health Care.
How Can Communication And Social Mobilization Help the DOTS Strategy? An Outcome Map To Strengthen DOTS Strategy To STOP TB © Johns Hopkins University.
Transition Program of HIV-infected adolescents to Adult HIV care in Buenos Aires, Argentina S. Arazi Caillaud 1, D. Mecikovsky 1, A.Bordato.
Directly Observed Therapy  Prescribed by a physician and required by policy for all public and private patients  Strategy to ensure uninterrupted TB.
Project Goals  Support the National Tb Program (NTP)  Developed National Guidelines for prevention and control of Tb  Developed guidelines for treating.
Progress of the Singapore TB Elimination Programme (STEP)
ISTC The Indonesian Experience Erlina Burhan Indonesian Society of Respirology ISTC Task Force Indonesian Medical Association.
Smear negative TB and HIV: urgent research priorities to inform a rolling global policy Haileyesus Getahun, MD, MPH, PhD Stop TB Department WHO/HQ.
Implementation of Thin Layer Agar for Mycobacterium culture in rural Kenya Médecins Sans Frontières.
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.
Implementation of Collaborative TB/HIV Activities by ICAP: Success and Challenges Andrea Howard, M.D., M.S. 14 th Core Group Meeting of TB/HIV Working.
The Health Roundtable 1-1d_HRT1212-Session_AUSTEN_GOSFORD_NSW Care Coordination decreases hospital reliance-Case Study Presenter: Alison Austen Central.
Universal access to TB care what is the challenge, what policy, what is being implemented Cancun 3 December 2009 Léopold BLANC and TBS team TBS/STB/WHO.
HIV/TB Interventions among Migrants in Thailand: A Community-Based Approach Jaruwaree Snidwongse, PhD Global Fund Principal Recipient Manager (TB) World.
Extrapulmonary Site 2 :_____________________ TUBERCULOSIS TREATMENT CARD BOTSWANA NATIONAL TUBERCULOSIS PROGRAMME Date RegisteredIN ToOUT RegisteredIN.
Challenges in adapting chronic HIV/TB services to high mobile populations in Southern Africa Eric Goemaere, MD Médecins Sans Frontières IAS Washington,
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
Introduction of outpatient care for DS-/MDR-TB patients in Tajikistan Cape Town, December 02-06, 2015.
Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.
TB and HIV integrated services at Martin Preuss Centre in Lilongwe, Malawi : “The Lighthouse Trust initiative” Dr Sam Phiri Executive Director Lighthouse.
Community Paramedic Primary Care Project.
South West Hepatitis C Needs Assessment Dr Maya Gobin Health Protection Services (South West)
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Taipei, June Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.
A Way out of Directly Observed Therapy (DOT): Community approaches to Self-Administered Treatment for Rifampicin Resistant Tuberculosis in Khayelitsha,
Using Detainees and Peer Educators in HIV prevention and systematic TB screening: Kigali Central Prison (PCK) Eugenie INGABIRE.
TB- HIV Collaborative activities in Romania- may 2006 status
1Médecins Sans Frontières (MSF), Sanaa, Yemen; 2MSF, Barcelona, Spain
Tuberculosis in children in Uzbekistan: Don’t forget drug-resistant TB Junia Cajazeiro, Atadjan Khamraev, Philip Du Cros, Tleubergen Abdrasuliev, Joan.
Blasco P1, Breitenecker F1, Fontaine C1, Seangkla P2, Ruthaiwat J2.
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
Update on SBCC Activities of Challenge TB Bangladesh
Implementing a TB-Control Program in Prisons: The Basics
Epidemiology of Tuberculosis in Hong Kong
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
5th edition NTP MANUAL OF PROCEDURES TB-DOTS Referral System
Lucas Molfino, MSF Mozambique
Presentation transcript:

MSF TB Program for Migrants in Tak

Beginnings: MSF TB Programs in Thailand First MSF TB Program in Thailand started in 1985 in Karen camps (Shoklo, Maela) Residential TB programs with high cure rate and low default rate (AFB (+ ): cure rate = 79,5% completed rate = 5,6% ; default rate = 5,6%) Programs not aimed at highly mobile populations crossing the border frequently

Migrant Healthcare: Multiple Challenges Large unregistered population of migrants in border areas; Tak province alone with estimated 75,000 to 150,000 unregistered migrants Barriers to medical care: -cost -security concerns (deportation) -linguistic and cultural barriers

MSF Migrant TB Program: Planning MSF pilot study of migrant factory workers in Maesod in 1999: undertaken with Thai public health and with MSH (Dr. Witaya) Census: 71 factories assessed; estimated migrant factory population of 16,000 Random sample of 1000 workers from census: primarily young adults, 72% single, intermediate education level, only 11% speak Thai, most work >6m in same factory, basic housing conditions- overcrowding with enhanced chance of spreading communicable disease Not included in census: day workers, farmers

MSF TB Program for Migrants: Implementation MSF TB program reviewed by Thai National TB program advisors and WHO technical advisors to ensure collaboration with Thai national TB program and implementation of DOTS in Thailand; DOTS launched on a national scale in 1996

MSF TB Program for Migrants: Objectives Target Population: 1)Factory Workers (est. 16,000) 2)Day workers (est. 10,000) 3)Farmers (rural population, difficult to access) 4)Patients crossing from Myanmar for medical care in Thailand Target Area: Maesot, Tak province and 20 km radius; later extended to Phoe Phra

MSF TB program TB Village, Maela Camp Chest Clinic, Maesod DOTS Program TB education for migrant factory workers MDR Program

Chest clinic, Maesod Referral sources: Self (factory teachings, etc.), Maesod Hospital, Mae Tao Clinic Facilities: Complex with 14 patient rooms, lab, pharmacy, consultation room Maesot TB team: 1 physician, 2 medics, 6 DOTS supervisors, 1 lab supervisor, 2 lab technicians, 1 driver; 1 cleaner and 2 cooks

Diagnosis and Treatment Diagnosis: Sputum x 3, no culture; other diagnostic modalities: CXR, fine needle aspiration, lymph node biopsy, thoracentesis. Treatment: WHO short course Category 1: 2HERZ/4HR Category 2: 2HERZS/HERZ/5HER Category 3: Same protocol as category 1

DOTS Program All TB treatment by DOTS short course; RX 6 times per week in Mae Sod and 3 times per week in Phoe Phrae Patient population: migrant, undocumented, movements restricted DOTS team meets patient at home or workplace by motor bike or car Patient identification cards ชื่อ … Winnie the Pooh อายุ ปี เพศ... Male บัตรผู้ป่วยเลขที่ วันที่ผู้ป่วยครบกำหนดการรักษา วันที่บัตรหมดอายุ ลายมือฃื่อ …Winnie the Pooh MEDECINS SANS FRONTIERES

Age and Sex of 311 M+ patients enrolled between Nov. 15, 1999 and Dec. 31, 2002 Age Group Male Female Total

Treatment Outcome in 311 new M+ Patients enrolled between Nov. 15, 1999 and Dec. 31, 2002 Outcome Number (%) of patients Cured 215 (69.1%) Completed 2 (.6%) Transfer out 11 (3.5%) Default 61 (19.6%) Died 8 (2.6%) success rate(cure +tx completed)=217/311 (69.7%)

Treatment Outcome in 508 patients enrolled between Nov. 15, 1999 and Dec. 31, 2002 Outcome Number (%) of patients Cured 256 (50.4%) Completed 100 (19.7%) Transfer out 14 (2.8%) Default 72 (14.2%) Failed 51 (10.0%) Died 15 (3.0%) success rate (cure + tx completed)=356/508(70.1%)

Treatment Outcome of 63 Cross Border patients enrolled between Nov. 15, 1999 and Dec. 31, 2002 Cured=6/63 (57%) Completed=5/63 (8%) Default=17/63 (27%) Fail= 3/63 (5%) Die= 2/63 (3%) In 2003, 54 cross border patients enrolled in DOTS, 17(31%) have already defaulted during tx. Another 10 pts did not start tx (default before tx).

Factory TB education and screening Factories in Mae Sot area with 20 to 2,000 migrant workers TB education program launched November 2002: TB transmission, symptoms, diagnosis, treatment discussed Offer of diagnostic sputum testing and treatment free of charge 37 factories visited in 2003 with approximately 6,500 workers attending sessions

MDR Program A residential treatment program at Maela started to address a growing public health problem First patients admitted in August 2001; 15 patients have been admitted to program since start Treatment regimen lasts at least 2 years Challenges: -continuing difficulties with drug importation -high default rate

Conclusions DOTS program for migrants has cure rates less than WHO target of 85% but given highly mobile population can be considered a success Keys to success: -security issues: medications brought to migrants; ID cards -coordination with other groups: Thai public health, MSH, WHO, Mae Tao Clinic, local authorities -culturally sensitive Burmese-speaking staff

Conclusions -2 DOTS Weak Points: -Program requires considerable investment of staff and resources -High default rates for ambulatory DOTS patients from Myanmar: cost, security concerns, inconvenience; other strategies: education based program, patient access on Myanmar side -No HIV testing or education done

Conclusions -3 Factory Education: Targeted education and case finding in factories worthwhile but program is hindered by continuing problems accessing factory owners (distrust of NGOs)